Primary Site >> Esophagus Cancer

Gene >> RHOA

  • 2006
  • 2007
  • 2012
  • 2014
  • 2015
  • 2016
  • 2018
Ref: RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
PMID: 16849557
Ref: Comparative integromics on FZD7 orthologs: conserved binding sites for PU.1, SP1, CCAAT-box and TCF/LEF/SOX transcription factors within 5'-promoter region of mammalian FZD7 orthologs.
PMID: 17273804
Ref: Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer.
PMID: 17308098
Ref: The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse.
PMID: 22015944
Ref: F-box protein complex FBXL19 regulates TGFbeta1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation.
PMID: 24684802
Ref: ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.
PMID: 25091467
Ref: Inhibition of Rho-associated kinases disturbs the collective cell migration of stratified TE-10 cells.
PMID: 26330114
Ref: Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer.
PMID: 26631033
Ref: Esophageal cancer cells resistant to T-DM1 display alterations in cell adhesion and the prostaglandin pathway.
PMID: 29765526
Ref: Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK.
PMID: 29777701
Ref: RAC2 promotes abnormal proliferation of quiescent cells by enhanced JUNB expression via the MAL-SRF pathway.
PMID: 29895215